Trastuzumab Emtansine (T-DM1): No radiosensitizing effect in vitro on HER2-positive breast cancer cells (study in vitro)

被引：0
|
作者：
Mignot, Fabien [1 ]
Kirova, Youlia [1 ]
Verrelle, Pierre [1 ]
Teulade-Fichou, Marie-Paule [1 ]
Megnin-Chanet, Frederique [1 ]
机构：
[1] Inst Curie, Paris, France
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P1-18-24
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-18-24
引用
收藏
页数：2
相关论文
共 50 条
  • [1] In vitro effects of Trastuzumab Emtansine (T-DM1) and concurrent irradiation on HER2-positive breast cancer cells
    Mignot, F.
    Kirova, Y.
    Verrelle, P.
    Teulade-Fichou, M-P
    Megnin-Chanet, F.
    [J]. CANCER RADIOTHERAPIE, 2021, 25 (02): : 126 - 134
  • [2] Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer
    Boyraz, Baris
    Sendur, Mehmet A. N.
    Aksoy, Sercan
    Babacan, Taner
    Roach, Emir C.
    Kizilarslanoglu, Muhammet C.
    Petekkaya, Ibrahim
    Altundag, Kadri
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (04) : 405 - 414
  • [3] Trastuzumab emtansine (T-DM1) for HER2-positive advanced breast cancer
    Thibault, C.
    [J]. ONCOLOGIE, 2013, 15 (02) : 126 - 127
  • [4] Trastuzumab emtansine (T-DM1) for the treatment of HER2-positive breast cancer
    Sliwkowski, Mark X.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [5] Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer
    Francis W. Hunter
    Hilary R. Barker
    Barbara Lipert
    Françoise Rothé
    Géraldine Gebhart
    Martine J. Piccart-Gebhart
    Christos Sotiriou
    Stephen M. F. Jamieson
    [J]. British Journal of Cancer, 2020, 122 : 603 - 612
  • [6] Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer
    Hunter, Francis W.
    Barker, Hilary R.
    Lipert, Barbara
    Rothe, Francoise
    Gebhart, Geraldine
    Piccart-Gebhart, Martine J.
    Sotiriou, Christos
    Jamieson, Stephen M. F.
    [J]. BRITISH JOURNAL OF CANCER, 2020, 122 (05) : 603 - 612
  • [7] Trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer and brain metastases
    Jacot, W.
    Pons, E.
    Guiu, S.
    Levy, C.
    Frenel, J-S
    Bachelot, T.
    D'Hondt, V.
    Firmin, N.
    Romieu, G.
    Thezenas, S.
    Dalenc, F.
    [J]. CANCER RESEARCH, 2016, 76
  • [8] Metastatic HER2-positive Breast Cancer New Perspectives with Trastuzumab Emtansine (T-DM1)
    Satzger, Ulla
    [J]. ONKOLOGIE, 2013, 36 (09): : 525 - 525
  • [9] The role of autophagy in the cytotoxicity induced by trastuzumab emtansine (T-DM1) in HER2-positive breast cancer cells
    Peipei Liu
    Jiajun Fan
    Ziyu Wang
    Wenjing Zai
    Ping Song
    Yongping Li
    Dianwen Ju
    [J]. AMB Express, 10
  • [10] The role of autophagy in the cytotoxicity induced by trastuzumab emtansine (T-DM1) in HER2-positive breast cancer cells
    Liu, Peipei
    Fan, Jiajun
    Wang, Ziyu
    Zai, Wenjing
    Song, Ping
    Li, Yongping
    Ju, Dianwen
    [J]. AMB EXPRESS, 2020, 10 (01)
12345